男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Experts: Innovative treatment needed in fight against chronic respiratory diseases

By Han Jingyan | chinadaily.com.cn | Updated: 2024-11-19 16:21
Share
Share - WeChat
Professor Klaus F. Rabe from the LungClinic Grosshansdorf, University of Kiel, delivers a keynote speech at the Respiratory Immunology International Summit. [Photo provided to chinadaily.com.cn]

As COPD is inherently a heterogeneous pulmonary condition persisting throughout the disease progression, Professor Klaus F. Rabe from the LungClinic Grosshansdorf, University of Kiel in Germany, stressed that 20 percent to 40 percent of COPD patients are primarily driven by type 2 inflammation pathways, and targeted therapies hold promise for meeting individual treatment needs.

Professor Wisia Wedzicha from Imperial College London stressed that clinical identification of inflammatory endotypes, particularly type 2 inflammation, is one of the prerequisites for precision COPD treatment.

Based on the results of inflammatory pathway studies, Professor Chen Yan from the Second Xiangya Hospital of Central South University underscored the vital role of biologics that target type 2 inflammation in managing chronic airway diseases, adding that since 2010, the exploration of biologics that target type 2 inflammation has been ongoing.

Professor Surya P. Bhatt from the University of Alabama in Birmingham delivers a keynote speech at the Respiratory Immunology International Summit. [Photo provided to chinadaily.com.cn]

Professor Surya P. Bhatt from the University of Alabama at Birmingham introduced biologics targeting key drivers in type 2 inflammation pathways and shared efficacy study results, expressing high expectations for biologics currently under investigation.

During the panel discussions, experts engaged in in-depth discussions on diagnostic and treatment strategies for COPD.

Professor Sun Dejun from Inner Mongolia People's Hospital delivers the closing summary at the Respiratory Immunology International Summit. [Photo provided to chinadaily.com.cn]

Professor Sun Dejun from Inner Mongolia People's Hospital remarked in his closing summary that the summit brought together top experts from around the world to deeply discuss the latest advancements in respiratory diseases, particularly targeting therapies. The insights gained offer valuable guidance for clinical practice, with the hope of benefiting more patients.

|<< Previous 1 2   
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 忻州市| 道孚县| 武强县| 临清市| 双柏县| 宁城县| 成都市| 兴和县| 龙游县| 皮山县| 阿城市| 锦州市| 东乡县| 平湖市| 常山县| 通道| 太保市| 清苑县| 五寨县| 泾阳县| 普定县| 通江县| 色达县| 凤台县| 伊宁市| 宣汉县| 丹江口市| 鹤壁市| 南丰县| 白城市| 新闻| 耿马| 子长县| 始兴县| 延安市| 永春县| 噶尔县| 鄂州市| 永吉县| 平乡县| 高青县|